Biden says 'very good' talks with Turk president    Egypt stands with Iraq in the face of all threats: Egyptian Foreign minister    APO Group, Getty Images make African press releases, images available globally    Luxor's comprehensive health insurance scheme gearing for 1 July launch    NATO: China is a constant security challenge    7th International Day of Yoga to be celebrated in Cairo    Swiss director Julia Bünter's Fiancées will open 22nd Ismailia Int'l Film Festival    Egypt's stocks finished in mixed notes as benchmark EGX 30 adds 0.47%    Egypt's Qalaa: chairman on no-fly list due to court ruling over unpaid $5 mln    Egypt could see 4-5 IPOs in H2: chairman    Fatura closes $3m pre-series A investment round    Disruptech Ventures leads funding round for Egypt's 1st agri-fintech platform    Group-IB uncovers ongoing large-scale scam targeting Middle East, Africa    America is back? Experts warn multiple issues threaten to divide NATO    Italian film 'Mi chiamo Francesco Totti' wins BankGiro Loterij Audience Award at IFFR    24th Shanghai Film Festival marks Communist Party of China centenary    With surge in virus, Oman faces shortage of hospital beds: AP report    Global financial institutions commit $80 bln to support Africa's sustainable recovery    Safwa Holding launches S-One in New Capital with EGP 750m in investments    Wandering elephants spotted flapping ears during sleep    Cairo Court announces 3 decisions in Zamalek apartment case    Egypt development projects in South Sudan serve as role model in Africa: Irrigation minister    Novavax: Large study finds COVID-19 shot about 90% effective    A potential Ahly CAF Champions League final game causes dilemma for Olympic team    Investing in Egypt 'right' decision amid stability, growth: French minister    Arab League in contact with Security Council to support Egypt, Sudan on GERD issue    Palestinian delegation in Cairo to discuss Gaza reconstruction    The Nile for Peace Initiative calls for reaching a legally-binding agreement over GERD issue    Shoukry accuses Ethiopia of obstructing efforts to reach GERD agreement    Egypt, UNFPA to discuss further support to achieve 2030 agenda    Palestinian-Jordanian The Synaptik and Egyptian Felukah rappers team up in 'Nefsi' single    APO Group enters new exclusive agreement with Getty Images on African press releases and images    Iconic Iraqi poet Saadi Youssef dies at 87 in London    Former Egypt foreign minister urges unified Arab action on 'fateful issues'    Denmark's Eriksen remains in hospital after collapse    Chile's Sanchez out of Copa America group stage with injury    Defending champions Brazil hosts Copa America    Saudi Arabia limits 2021 Hajj pilgrimage to citizens, residents    France's Benzema eyes national team return    Egypt is on short list of partner countries for U.S. COVID-19 vaccines: embassy    Russia to resume charter flights to Egypt resorts in the coming days    Biden administration to send surplus U.S. COVID-19 vaccines to Egypt, several countries    Russia expects to resume charter flights to Egypt resorts in near future    Egypt's Sisi announces allocation of $500 million for reconstruction in war-wrecked Gaza    On International Museum Day, Egypt opens two new museums at Cairo Airport    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Britain nears $625 mln Sanofi/GSK COVID-19 vaccine deal -report
Published in Ahram Online on 05 - 07 - 2020

Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine, the Sunday Times reported.
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year, sooner than previously anticipated.
More than 100 vaccines are being developed and tested around the world to stop the COVID-19 pandemic and governments are racing to secure supplies of vaccines even before their efficacy is proven.
A supply agreement with Sanofi and GSK would be Britain's second such deal, after it said it would buy 100 million doses of the Oxford-AstraZeneca vaccine.
Sanofi was not immediately available to comment, while a spokesman for GSK declined to comment. Both have both said they are prioritising quality over speed in developing a vaccine.
"The Government's Vaccines Task Force is actively engaging with a wide range of companies both in the UK and abroad to negotiate access to vaccines," a spokeswoman for Britain's business ministry, said, without confirming if Sanofi or GSK were among them.
The Sunday Times report said that Britain was considering taking an option to buy the vaccine should it work in human trials, and would see the amount paid in stages.
Sanofi is working on two possible COVID-19 vaccines, one of which uses an adjuvant made by GSK to potentially boost its efficacy, and has said it has capacity to produce up to 1 billion doses a year.
Its timeline for clinical trials is behind the likes of Moderna Inc, the University of Oxford in collaboration with AstraZeneca Plc, and an alliance of BioNTech and Pfizer Inc, whose projects all grabbed headlines by moving to human trials as early as March.
Sanofi has received financial backing from the United States and caused a stir in its home base of France after its British CEO Paul Hudson signalled that Europe was being too slow in supporting work on a vaccine, hinting U.S. patients might get any vaccine it develops first.
The EU is also seeking a deal with Sanofi, and has invited Britain to join its efforts to buy vaccines for the bloc. ($1 = 0.8011 pounds)


Clic here to read the story from its source.